Recent Advances in Targeted Therapies for Advanced Gastrointestinal Malignancies
Sign Up to like & getrecommendations! Published in 2020 at "Cancers"
DOI: 10.3390/cancers12051168
Abstract: The treatment of advanced gastrointestinal (GI) cancers has become increasingly molecularly driven. Molecular profiling for HER2 and PD-L1 status is standard for metastatic gastroesophageal (GEJ) cancers to predict benefits from trastuzumab (HER2-targeted therapy) and pembrolizumab… read more here.
Keywords: advanced gastrointestinal; targeted therapies; advances targeted; recent advances ... See more keywords